GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86−0.03 (-1.84%)
Close on Nov 13, 2026Market cap $84.38MP/E –Yield –
Genelux operating margin
Operating margin is operating income as a percentage of revenue.
Genelux's operating margin for the twelve months ending Dec 31, 2024 was -396200.0%. For fiscal 2025 it was -415175.0%, against -396200.0% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -415175.0% | −18975.0 |
| FY2024 | Dec 31, 2024 | -396200.0% | −381985.3 |
| FY2023 | Dec 31, 2023 | -14214.7% | −14187.5 |
| FY2022 | Dec 31, 2022 | -27.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -101437.5% | – |
| Q1 FY2023 | Mar 31, 2023 | -3801.2% | – |
| Q4 FY2022 | Dec 31, 2022 | -4550.0% | – |
| Q3 FY2022 | Sep 30, 2022 | 57.7% | – |
See a number that looks wrong?